His specialization in biomedical research, particularly cancer-related research and clinical settings, is a testament to his passion.
CAPE CHARLES, VA, April 30, 2024 /24-7PressRelease/ -- Dr. David Irwin has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Dr. Irwin, a man of unwavering dedication, draws on years of professional experience to excel as the president of the eponymous Irwin Consulting. His specialization in biomedical research, particularly cancer-related research and clinical settings, is a testament to his passion. He develops strategies to obtain research funding and writes proposals, designs funding programs, and evaluates their impact. Before founding his practice, Dr. Irwin was a senior scientist and program director at the American Institute for Biological Sciences and the managing director of science and education for the American Association for Cancer Research.
Dr. Irwin's career trajectory is marked by significant contributions to the field. During the early stages of his career, he gained valuable expertise as the associate director of St. Jude Children's Research Hospital and Georgetown University's Lombardi Comprehensive Cancer Center. His consultation for esteemed organizations such as the American Society of Clinical Oncology, the Constella Group, SRA International, Pancagen, Inc., and the American Institute of Biological Sciences further solidified his reputation. His vast breadth of knowledge has led to numerous publications and abstracts, including "A Tissue-Specific Code Based on the Abundance of SDS-Solubilized Proteins," "The Validation of Peer Review through Research Impact Measures and the Implications for Funding Strategies," "Selective Increases in the Activities of Rat Liver Polysomes Following Burn Trauma," and "Life and Death Under Covid 19."
Before establishing himself in biomedical research, Dr. Irwin earned a bachelor's degree in applied chemistry from the University of Leeds. Subsequently, he expanded his professional knowledge by completing a PhD in fibrous protein biosynthesis at Leeds Beckett University and postdoctoral studies in biochemistry and surgery at Harvard Medical School. In conjunction with his work, Dr. Irwin has contributed to his community as scoutmaster at the Darnestown Presbyterian Church.
In light of his professional achievements, Dr. Irwin received a Merit and Special Award from the National Institutes of Health. While his career has been filled with highlights, he takes the most pride in being recruited to St. Jude Children's Research Hospital and the Lombardi Cancer Center due to his expertise in grants and peer review. Though hard work and dedication have brought him far in his career, he credits his success to the positive influence of his role models, including his thesis adviser and colleague. In the coming years, Dr. Irwin intends to continue meta-research into why the current research focus of Alzheimer's disease drug development has proved to be disappointing. Other approaches using drugs for hypertension have been under-explored.
About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Marquis celebrates its 125th anniversary in 2023, and Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® publications may be visited at the official Marquis Who's Who® website at www.marquiswhoswho.com.
# # #